In a recent call with Wall Street analysts, the North Carolina clinical trial suite etrials reported rapid growth and remains hopeful about the future. Gross revenues for the third quarter jumped 46 percent to $4.8 million from $3.3 million. Over the previous nine months, the company operated at a loss,…more...
Not long ago, we had a chat with Steven F. Crowley of Craig-Hallum. He’s managing director of health care research at the company, which is an investment boutique in Minneapolis, Minnesota. The firm helps institutional investors find big opportunities. There are slim pickings in the healthcare IT investment world at…more...
Phase Forward’s steady growth continues, an impressive feat for one of the larger technology companies in the industry. The company reported a 26 percent rise on revenues of $28 million. There was a 37 percent jump in a variety of revenues related to its electronic data capture (EDC) program, InForm.…more...
The British firm ClinPhone purchased DataLabs, a middle-tier provider of electronic data capture (EDC) software. “The assimilation of an established EDC product with our leading suite of IVR, IWR, CTMS and ePRO solutions gives sponsors a choice that they haven’t previously enjoyed,” said Steve Kent, ClinPhone’s CEO. “We are already…more...
Deloitte named the next batch of Fast 500 companies. etrials is 363rd on the list. Since 2001, etrials says, it has grown its revenues by 345 percent; this is the company’s second consecutive appearance on the list. “Sophisticated technology is becoming the norm and is in almost everything in the…more...
Phase Forward has unveiled a new version of software that helps identify drug safety issues and manage the data in a non-proprietary, Clinical Data Interchange Standards Consortium (CDISC-compliant) manner. The latest version of the Clinical Trials Signal Detection system (CTSD) includes “a newly developed issue cluster mining technique, enhanced statistical…more...
The electronic data capture (EDC) company etrials reported $2 million in new contracts last month. The company said the five new contracts in September represented additional work for three current clients and one new customer. None were named. A medical device firm will use etrials and explore e-clinical technology for…more...
Nextrials announced it had been selected in midstream by ArQule to take over data-capture chores in a Phase I-II study. Arqule recently exited the chemistry business to focus its quest to develop new drugs using its own scientific tools. ArQule says it has ongoing projects with Roche; former collaborations include…more...
Clinical data management is not really an endangered species. But it is threatened. That’s because some companies believe that massive, traditional systems to manage clinical trial data could be made obsolete by electronic data capture (EDC) tools that do some of the same tasks. An Asian contract research organization (CRO)…more...
Afferenz is repositioning itself. The company operates in the U.S. but is a unit of Megasoft Consultants of India. Ven Thangaraj, president of Afferenz, is responsible for driving the strategic direction of the company. Its main product, Acceliant eClinical Suite, offers users real-time efficiency, ease-of-use in trial design, unparalleled flexibility,…more...
January 8, 2009
Tying electronic data capture (EDC) to other systems remains a challenge, our authors say. The second article in a series.
In this installment, two leading EDC supplier discuss what they’re doing to appeal to—and collaborate with—CROs.
A new name for the safety products from Phase Forward, plus insights into faster responses to safety crises.
Why Bio-Imaging bought a top electronic data capture company.
ACS talks about a new product. The company is betting the combination of EDC and CTMS will appeal to biotech firms and contract research organizations.
Almac Clinical Technologies is adding electronic data capture to its expedited service offering.
Organizations
Conferences
Info & Opinion
